1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Neurotrophins Revenue
1.4 Market Analysis by Type
1.4.1 Global Neurotrophins Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Nerve Growth Factor
1.4.3 Brain-Derived Neurotrophic Factor
1.4.4 Dehydroepiandrosterone Sulfate
1.4.5 Other
1.5 Market by Application
1.5.1 Global Neurotrophins Market Share by Application: 2021-2026
1.5.2 Alzheimer'S Disease
1.5.3 Amyotrophic Lateral Sclerosis
1.5.4 Parkinson'S Disease
1.5.5 Other
1.6 Study Objectives
1.7 Years Considered
1.8 Overview of Global Neurotrophins Market
1.8.1 Global Neurotrophins Market Status and Outlook (2015-2026)
1.8.2 North America
1.8.3 East Asia
1.8.4 Europe
1.8.5 South Asia
1.8.6 Southeast Asia
1.8.7 Middle East
1.8.8 Africa
1.8.9 Oceania
1.8.10 South America
1.8.11 Rest of the World
2 Market Competition by Manufacturers
2.1 Global Neurotrophins Production Capacity Market Share by Manufacturers (2015-2020)
2.2 Global Neurotrophins Revenue Market Share by Manufacturers (2015-2020)
2.3 Global Neurotrophins Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Neurotrophins Production Sites, Area Served, Product Type
3 Sales by Region
3.1 Global Neurotrophins Sales Volume Market Share by Region (2015-2020)
3.2 Global Neurotrophins Sales Revenue Market Share by Region (2015-2020)
3.3 North America Neurotrophins Sales Volume
3.3.1 North America Neurotrophins Sales Volume Growth Rate (2015-2020)
3.3.2 North America Neurotrophins Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.4 East Asia Neurotrophins Sales Volume
3.4.1 East Asia Neurotrophins Sales Volume Growth Rate (2015-2020)
3.4.2 East Asia Neurotrophins Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.5 Europe Neurotrophins Sales Volume (2015-2020)
3.5.1 Europe Neurotrophins Sales Volume Growth Rate (2015-2020)
3.5.2 Europe Neurotrophins Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.6 South Asia Neurotrophins Sales Volume (2015-2020)
3.6.1 South Asia Neurotrophins Sales Volume Growth Rate (2015-2020)
3.6.2 South Asia Neurotrophins Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.7 Southeast Asia Neurotrophins Sales Volume (2015-2020)
3.7.1 Southeast Asia Neurotrophins Sales Volume Growth Rate (2015-2020)
3.7.2 Southeast Asia Neurotrophins Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.8 Middle East Neurotrophins Sales Volume (2015-2020)
3.8.1 Middle East Neurotrophins Sales Volume Growth Rate (2015-2020)
3.8.2 Middle East Neurotrophins Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.9 Africa Neurotrophins Sales Volume (2015-2020)
3.9.1 Africa Neurotrophins Sales Volume Growth Rate (2015-2020)
3.9.2 Africa Neurotrophins Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.10 Oceania Neurotrophins Sales Volume (2015-2020)
3.10.1 Oceania Neurotrophins Sales Volume Growth Rate (2015-2020)
3.10.2 Oceania Neurotrophins Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.11 South America Neurotrophins Sales Volume (2015-2020)
3.11.1 South America Neurotrophins Sales Volume Growth Rate (2015-2020)
3.11.2 South America Neurotrophins Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.12 Rest of the World Neurotrophins Sales Volume (2015-2020)
3.12.1 Rest of the World Neurotrophins Sales Volume Growth Rate (2015-2020)
3.12.2 Rest of the World Neurotrophins Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
4 North America
4.1 North America Neurotrophins Consumption by Countries
4.2 United States
4.3 Canada
4.4 Mexico
5 East Asia
5.1 East Asia Neurotrophins Consumption by Countries
5.2 China
5.3 Japan
5.4 South Korea
6 Europe
6.1 Europe Neurotrophins Consumption by Countries
6.2 Germany
6.3 United Kingdom
6.4 France
6.5 Italy
6.6 Russia
6.7 Spain
6.8 Netherlands
6.9 Switzerland
6.10 Poland
7 South Asia
7.1 South Asia Neurotrophins Consumption by Countries
7.2 India
7.3 Pakistan
7.4 Bangladesh
8 Southeast Asia
8.1 Southeast Asia Neurotrophins Consumption by Countries
8.2 Indonesia
8.3 Thailand
8.4 Singapore
8.5 Malaysia
8.6 Philippines
8.7 Vietnam
8.8 Myanmar
9 Middle East
9.1 Middle East Neurotrophins Consumption by Countries
9.2 Turkey
9.3 Saudi Arabia
9.4 Iran
9.5 United Arab Emirates
9.6 Israel
9.7 Iraq
9.8 Qatar
9.9 Kuwait
9.10 Oman
10 Africa
10.1 Africa Neurotrophins Consumption by Countries
10.2 Nigeria
10.3 South Africa
10.4 Egypt
10.5 Algeria
10.6 Morocco
11 Oceania
11.1 Oceania Neurotrophins Consumption by Countries
11.2 Australia
11.3 New Zealand
12 South America
12.1 South America Neurotrophins Consumption by Countries
12.2 Brazil
12.3 Argentina
12.4 Columbia
12.5 Chile
12.6 Venezuela
12.7 Peru
12.8 Puerto Rico
12.9 Ecuador
13 Rest of the World
13.1 Rest of the World Neurotrophins Consumption by Countries
13.2 Kazakhstan
14 Sales Volume, Sales Revenue, Sales Price Trend by Type
14.1 Global Neurotrophins Sales Volume Market Share by Type (2015-2020)
14.2 Global Neurotrophins Sales Revenue Market Share by Type (2015-2020)
14.3 Global Neurotrophins Sales Price by Type (2015-2020)
15 Consumption Analysis by Application
15.1 Global Neurotrophins Consumption Volume by Application (2015-2020)
15.2 Global Neurotrophins Consumption Value by Application (2015-2020)
16 Company Profiles and Key Figures in Neurotrophins Business
16.1 Johnson?Johnson
16.1.1 Johnson?Johnson Company Profile
16.1.2 Johnson?Johnson Neurotrophins Product Specification
16.1.3 Johnson?Johnson Neurotrophins Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.2 GE Healthcare
16.2.1 GE Healthcare Company Profile
16.2.2 GE Healthcare Neurotrophins Product Specification
16.2.3 GE Healthcare Neurotrophins Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.3 Scil Proteins GmbH
16.3.1 Scil Proteins GmbH Company Profile
16.3.2 Scil Proteins GmbH Neurotrophins Product Specification
16.3.3 Scil Proteins GmbH Neurotrophins Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.4 Lonza Groups
16.4.1 Lonza Groups Company Profile
16.4.2 Lonza Groups Neurotrophins Product Specification
16.4.3 Lonza Groups Neurotrophins Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.5 PeproTech
16.5.1 PeproTech Company Profile
16.5.2 PeproTech Neurotrophins Product Specification
16.5.3 PeproTech Neurotrophins Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.6 FibroGen
16.6.1 FibroGen Company Profile
16.6.2 FibroGen Neurotrophins Product Specification
16.6.3 FibroGen Neurotrophins Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.7 Scil Proteins GmbH
16.7.1 Scil Proteins GmbH Company Profile
16.7.2 Scil Proteins GmbH Neurotrophins Product Specification
16.7.3 Scil Proteins GmbH Neurotrophins Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.8 Merck Serono
16.8.1 Merck Serono Company Profile
16.8.2 Merck Serono Neurotrophins Product Specification
16.8.3 Merck Serono Neurotrophins Production Capacity, Revenue, Price and Gross Margin (2015-2020)
17 Neurotrophins Manufacturing Cost Analysis
17.1 Neurotrophins Key Raw Materials Analysis
17.1.1 Key Raw Materials
17.2 Proportion of Manufacturing Cost Structure
17.3 Manufacturing Process Analysis of Neurotrophins
17.4 Neurotrophins Industrial Chain Analysis
18 Marketing Channel, Distributors and Customers
18.1 Marketing Channel
18.2 Neurotrophins Distributors List
18.3 Neurotrophins Customers
19 Market Dynamics
19.1 Market Trends
19.2 Opportunities and Drivers
19.3 Challenges
19.4 Porter's Five Forces Analysis
20 Production and Supply Forecast
20.1 Global Forecasted Production of Neurotrophins (2021-2026)
20.2 Global Forecasted Revenue of Neurotrophins (2021-2026)
20.3 Global Forecasted Price of Neurotrophins (2015-2026)
20.4 Global Forecasted Production of Neurotrophins by Region (2021-2026)
20.4.1 North America Neurotrophins Production, Revenue Forecast (2021-2026)
20.4.2 East Asia Neurotrophins Production, Revenue Forecast (2021-2026)
20.4.3 Europe Neurotrophins Production, Revenue Forecast (2021-2026)
20.4.4 South Asia Neurotrophins Production, Revenue Forecast (2021-2026)
20.4.5 Southeast Asia Neurotrophins Production, Revenue Forecast (2021-2026)
20.4.6 Middle East Neurotrophins Production, Revenue Forecast (2021-2026)
20.4.7 Africa Neurotrophins Production, Revenue Forecast (2021-2026)
20.4.8 Oceania Neurotrophins Production, Revenue Forecast (2021-2026)
20.4.9 South America Neurotrophins Production, Revenue Forecast (2021-2026)
20.4.10 Rest of the World Neurotrophins Production, Revenue Forecast (2021-2026)
20.5 Forecast by Type and by Application (2021-2026)
20.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2021-2026)
20.5.2 Global Forecasted Consumption of Neurotrophins by Application (2021-2026)
21 Consumption and Demand Forecast
21.1 North America Forecasted Consumption of Neurotrophins by Country
21.2 East Asia Market Forecasted Consumption of Neurotrophins by Country
21.3 Europe Market Forecasted Consumption of Neurotrophins by Countriy
21.4 South Asia Forecasted Consumption of Neurotrophins by Country
21.5 Southeast Asia Forecasted Consumption of Neurotrophins by Country
21.6 Middle East Forecasted Consumption of Neurotrophins by Country
21.7 Africa Forecasted Consumption of Neurotrophins by Country
21.8 Oceania Forecasted Consumption of Neurotrophins by Country
21.9 South America Forecasted Consumption of Neurotrophins by Country
21.10 Rest of the world Forecasted Consumption of Neurotrophins by Country
22 Research Findings and Conclusion
23 Methodology and Data Source
23.1 Methodology/Research Approach
23.1.1 Research Programs/Design
23.1.2 Market Size Estimation
23.1.3 Market Breakdown and Data Triangulation
23.2 Data Source
23.2.1 Secondary Sources
23.2.2 Primary Sources
23.3 Disclaimer